The survey was conducted by Health Catalyst and queried CIOs, CMIOs and CMOs of health systems. Notable findings included:
- 59 percent of respondents said precision medicine will not play a significant role in their organization in the next five years.
- 68 percent of respondents said precision medicine will play a non-existent, small or average role in their organizations between now and 2020.
- 63 percent of respondents said their organizations had no plans to integrate genomic data into their EHRs, although 50 percent agree genomic data could have a positive impact on their patient treatment strategies.
- 71 percent of respondents from academic medical centers said precision medicine would play a significant role in their organizations in the next five years.
- 64 percent of respondents from academic medical centers they plan to integrate genomic data into their EHRs.
More articles on health IT:
Senate won’t take up 21st Century Cures bill
Stanford Medicine dean: Instead of precision medicine, let’s focus on precision health
Why interoperability still eludes healthcare: Q&A with Dr. Charles Jaffe, CEO of HL7
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
